Market
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| Altay TherapeuticsQuiet$15.7M of $45.1M · Series A · Health & bio · 506(b) · San Carlos, CA · 2026-10-02New | Altay TherapeuticsNew | Health & bio | Series A | $15.7M of $45.1MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-04How this is computed → | 2026-10-02 | San Carlos, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| CAD TherapeuticsQuiet$4.0M of $10.0M · Seed · Health & bio · 506(b) · New York, NY · 2026-10-02New | CAD TherapeuticsNew | Health & bio | Seed | $4.0M of $10.0MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-04How this is computed → | 2026-10-02 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| Amani TherapeuticsQuiet$35.0M of $60.0M · Series B · Health & bio · 506(b) · New York, NY · 2026-10-01New | Amani TherapeuticsNew | Health & bio | Series B | $35.0M of $60.0MAmount sold of the amount offered on the filing of 2026-10-01 · as of 2026-10-04How this is computed → | 2026-10-01 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| VETmAb BiosciencesQuiet$11.4M of $11.9M · Series A · Health & bio · 506(b) · San Diego, CA · 2026-09-29New | VETmAb BiosciencesNew | Health & bio | Series A | $11.4M of $11.9MAmount sold of the amount offered on the filing of 2026-09-29 · as of 2026-10-04How this is computed → | 2026-09-29 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| Sialia Therapeutics, Inc.Quiet$1.5M of $1.5M · Seed · Health & bio · 506(b) · Irvine, CA · 2026-09-29New | Sialia Therapeutics, Inc.New | Health & bio | Seed | $1.5M of $1.5MAmount sold of the amount offered on the filing of 2026-09-29 · as of 2026-10-04How this is computed → | 2026-09-29 | Irvine, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| Xact BioQuiet$10.0M of $18.0M · Series A · Health & bio · 506(b) · Boston, MA · 2026-09-28New | Xact BioNew | Health & bio | Series A | $10.0M of $18.0MAmount sold of the amount offered on the filing of 2026-09-28 · as of 2026-10-04How this is computed → | 2026-09-28 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| Navigator MedicinesQuiet$10.0M of $40.0M · Series A · Health & bio · 506(b) · San Mateo, CA · 2026-09-25 | Navigator Medicines | Health & bio | Series A | $10.0M of $40.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-04How this is computed → | 2026-09-25 | San Mateo, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| SeraxisQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Germantown, MD · 2026-09-24 | Seraxis | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-09-24 · as of 2026-10-04How this is computed → | 2026-09-24 | Germantown, MD | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Caspian TherapeuticsQuiet$50.0M of $50.0M · Series B · Health & bio · 506(b) · San Diego, CA · 2026-09-23 | Caspian Therapeutics | Health & bio | Series B | $50.0M of $50.0MAmount sold of the amount offered on the filing of 2026-09-23 · as of 2026-10-04How this is computed → | 2026-09-23 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Typewriter TherapeuticsHiring actively$56.3M of $56.3M · Series B · Health & bio · 506(b) · Cambridge, MA · 2026-09-21 | Typewriter Therapeutics | Health & bio | Series B | $56.3M of $56.3MAmount sold of the amount offered on the filing of 2026-09-21 · as of 2026-10-04How this is computed → | 2026-09-21 | Cambridge, MA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Avery TherapeuticsQuiet$8.5M of $15.4M · Series A · Health & bio · 506(b) · Tucson, AZ · 2026-09-21 | Avery Therapeutics | Health & bio | Series A | $8.5M of $15.4MAmount sold of the amount offered on the filing of 2026-09-21 · as of 2026-10-04How this is computed → | 2026-09-21 | Tucson, AZ | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Aqur BiosciencesQuiet$1.5M of $1.5M · Seed · Health & bio · 506(b) · Westlake Village, CA · 2026-09-18 | Aqur Biosciences | Health & bio | Seed | $1.5M of $1.5MAmount sold of the amount offered on the filing of 2026-09-18 · as of 2026-10-04How this is computed → | 2026-09-18 | Westlake Village, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Moonwalk BiosciencesHiring actively$60.0M of $70.2M · Series B · Health & bio · 506(b) · South San Francisco, CA · 2026-09-14 | Moonwalk Biosciences | Health & bio | Series B | $60.0M of $70.2MAmount sold of the amount offered on the filing of 2026-09-14 · as of 2026-10-04How this is computed → | 2026-09-14 | South San Francisco, CA | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Tempo TherapeuticsHiring actively$14.0M of $14.5M · Series A · Health & bio · 506(b) · San Diego, CA · 2026-09-11 | Tempo Therapeutics | Health & bio | Series A | $14.0M of $14.5MAmount sold of the amount offered on the filing of 2026-09-11 · as of 2026-10-04How this is computed → | 2026-09-11 | San Diego, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| AlzheonQuiet$78.8M of $500M · Series C+ · Health & bio · 506(b) · Framingham, MA · 2026-09-10 | Alzheon | Health & bio | Series C+ | $78.8M of $500MAmount sold of the amount offered on the filing of 2026-09-10 · as of 2026-10-04How this is computed → | 2026-09-10 | Framingham, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Iambic TherapeuticsHiring actively$66.0M of $66.5M · Series C+ · Health & bio · 506(b) · San Diego, CA · 2026-09-09AI-native | Iambic TherapeuticsAI-native | Health & bio | Series C+ | $66.0M of $66.5MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | San Diego, CA | 506(b) | 32The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Airway TherapeuticsHiring actively$43.5M of $50.6M · Series B · Health & bio · 506(b) · Marietta, GA · 2026-09-09 | Airway Therapeutics | Health & bio | Series B | $43.5M of $50.6MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | Marietta, GA | 506(b) | 2The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Cloverleaf BioQuiet$14.8M of $29.6M · Series A · Health & bio · 506(b) · New Haven, CT · 2026-09-09 | Cloverleaf Bio | Health & bio | Series A | $14.8M of $29.6MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | New Haven, CT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Animal BioscienceQuiet$2.3M of $2.6M · Seed · Health & bio · 506(b) · Boston, MA · 2026-09-09 | Animal Bioscience | Health & bio | Seed | $2.3M of $2.6MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ImmunophotonicsQuiet$10.1M · Series A · Health & bio · 506(b) · St. Louis, MO · 2026-09-04 | Immunophotonics | Health & bio | Series A | $10.1MAmount sold on the filing of 2026-09-04 · as of 2026-10-04How this is computed → | 2026-09-04 | St. Louis, MO | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Superluminal MedicinesQuiet$65.5M of $65.5M · Series C+ · Health & bio · 506(b) · Boston, MA · 2026-09-03AI-native | Superluminal MedicinesAI-native | Health & bio | Series C+ | $65.5M of $65.5MAmount sold of the amount offered on the filing of 2026-09-03 · as of 2026-10-04How this is computed → | 2026-09-03 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Dravite Therapeutics, Inc.Quiet$53.0M of $53.0M · Series B · Health & bio · 506(b) · San Francisco, CA · 2026-09-03 | Dravite Therapeutics, Inc. | Health & bio | Series B | $53.0M of $53.0MAmount sold of the amount offered on the filing of 2026-09-03 · as of 2026-10-04How this is computed → | 2026-09-03 | San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Plowshare TherapiesQuiet$6.7M of $6.7M · Series A · Health & bio · 506(b) · Lancaster, PA · 2026-08-31 | Plowshare Therapies | Health & bio | Series A | $6.7M of $6.7MAmount sold of the amount offered on the filing of 2026-08-31 · as of 2026-10-04How this is computed → | 2026-08-31 | Lancaster, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Halia TherapeuticsQuiet$3.5M of $20.0M · Seed · Health & bio · 506(b) · Lehi, UT · 2026-08-31 | Halia Therapeutics | Health & bio | Seed | $3.5M of $20.0MAmount sold of the amount offered on the filing of 2026-08-31 · as of 2026-10-04How this is computed → | 2026-08-31 | Lehi, UT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| DalCor PharmaceuticalsQuiet$7.0M of $7.0M · Series A · Health & bio · 506(b) · Sarasota, FL · 2026-08-28 | DalCor Pharmaceuticals | Health & bio | Series A | $7.0M of $7.0MAmount sold of the amount offered on the filing of 2026-08-28 · as of 2026-10-04How this is computed → | 2026-08-28 | Sarasota, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AEGLE TherapeuticsQuiet$2.3M of $2.3M · Seed · Health & bio · 506(b) · Woburn, MA · 2026-08-28 | AEGLE Therapeutics | Health & bio | Seed | $2.3M of $2.3MAmount sold of the amount offered on the filing of 2026-08-28 · as of 2026-10-04How this is computed → | 2026-08-28 | Woburn, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Noveome BiotherapeuticsQuiet$6.8M of $15.0M · Series A · Health & bio · 506(b) · Pittsburgh, PA · 2026-08-27 | Noveome Biotherapeutics | Health & bio | Series A | $6.8M of $15.0MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Pittsburgh, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Platform Therapeutics (PTX)Quiet$1.8M of $4.0M · Seed · Health & bio · 506(b) · Andover, MA · 2026-08-27 | Platform Therapeutics (PTX) | Health & bio | Seed | $1.8M of $4.0MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Andover, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| FluidForm BioQuiet$1.7M of $3.0M · Seed · Health & bio · 506(b) · Waltham, MA · 2026-08-27 | FluidForm Bio | Health & bio | Seed | $1.7M of $3.0MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Waltham, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Epicrispr BiotechnologiesQuiet$177M of $213M · Series C+ · Health & bio · 506(b) · South San Francisco, CA · 2026-08-26 | Epicrispr Biotechnologies | Health & bio | Series C+ | $177M of $213MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | South San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Codebreaker Tx, Inc.Quiet$5.9M of $7.4M · Seed · Health & bio · 506(b) · Boulder, CO · 2026-08-26 | Codebreaker Tx, Inc. | Health & bio | Seed | $5.9M of $7.4MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | Boulder, CO | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ProEncia BiotechnologyQuiet$1.5M of $2.0M · Seed · Health & bio · 506(b) · Woodbury, MN · 2026-08-26 | ProEncia Biotechnology | Health & bio | Seed | $1.5M of $2.0MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | Woodbury, MN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Axiom TherapeuticsQuiet$12.3M of $12.3M · Series A · Health & bio · 506(b) · Claymont, DE · 2026-08-25AI-native | Axiom TherapeuticsAI-native | Health & bio | Series A | $12.3M of $12.3MAmount sold of the amount offered on the filing of 2026-08-25 · as of 2026-10-04How this is computed → | 2026-08-25 | Claymont, DE | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Unravel BiosciencesQuiet$4.1M of $4.5M · Seed · Health & bio · 506(b) · Medford, MA · 2026-08-24AI-native | Unravel BiosciencesAI-native | Health & bio | Seed | $4.1M of $4.5MAmount sold of the amount offered on the filing of 2026-08-24 · as of 2026-10-04How this is computed → | 2026-08-24 | Medford, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| FSH TechnologiesQuiet$24.1M of $24.1M · Series A · Health & bio · 506(b) · Philadelphia, PA · 2026-08-21 | FSH Technologies | Health & bio | Series A | $24.1M of $24.1MAmount sold of the amount offered on the filing of 2026-08-21 · as of 2026-10-04How this is computed → | 2026-08-21 | Philadelphia, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Outer BioQuiet$23.3M of $23.3M · Series A · Health & bio · 506(b) · Malden, MA · 2026-08-21 | Outer Bio | Health & bio | Series A | $23.3M of $23.3MAmount sold of the amount offered on the filing of 2026-08-21 · as of 2026-10-04How this is computed → | 2026-08-21 | Malden, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| EXUMA BiotechQuiet$70.0M of $70.0M · Series C+ · Health & bio · 506(b) · West Palm Beach, FL · 2026-08-20 | EXUMA Biotech | Health & bio | Series C+ | $70.0M of $70.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | West Palm Beach, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AmplificaQuiet$25.0M of $25.0M · Series B · Health & bio · 506(b) · San Diego, CA · 2026-08-20 | Amplifica | Health & bio | Series B | $25.0M of $25.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Sentonix, Inc.Quiet$12.7M of $21.2M · Series A · Health & bio · 506(b) · Arlington, MA · 2026-08-20 | Sentonix, Inc. | Health & bio | Series A | $12.7M of $21.2MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Arlington, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| LifeCyte InnovationsQuiet$1.0M of $5.0M · Pre-seed · Health & bio · 506(b) · Greensboro, GA · 2026-08-20 | LifeCyte Innovations | Health & bio | Pre-seed | $1.0M of $5.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Greensboro, GA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet |